Exploring the intersectionality of race/ethnicity with rurality on breast cancer outcomes: SEER analysis, 2000–2016

Author:

Moore Justin XavierORCID,Andrzejak Sydney Elizabeth,Jones Samantha,Han Yunan

Abstract

Abstract Purpose Disparities in breast cancer survival have been observed within marginalized racial/ethnic groups and within the rural–urban continuum for decades. We examined whether there were differences among the intersectionality of race/ethnicity and rural residence on breast cancer outcomes. Methods We performed a retrospective analysis among 739,448 breast cancer patients using Surveillance Epidemiology and End Results (SEER) 18 registries years 2000 through 2016. We conducted multilevel logistic-regression and Cox proportional hazards models to estimate adjusted odds ratios (AORs) and hazard ratios (AHRs), respectively, for breast cancer outcomes including surgical treatment, radiation therapy, chemotherapy, late-stage disease, and risk of breast cancer death. Rural was defined as 2013 Rural–Urban Continuum Codes (RUCC) of 4 or greater. Results Compared with non-Hispanic white–urban (NH-white–U) women, NH-black–U, NH-black–rural (R), Hispanic–U, and Hispanic–R women, respectively, were at increased odds of no receipt of surgical treatment (NH-black–U, AOR = 1.98, 95% CI 1.91–2.05; NH-black–R, AOR = 1.72, 95% CI 1.52–1.94; Hispanic–U, AOR = 1.58, 95% CI 1.52–1.65; and Hispanic–R, AOR = 1.40, 95% CI 1.18–1.67), late-stage diagnosis (NH-black–U, AOR = 1.32, 95% CI 1.29–1.34; NH-black–R, AOR = 1.29, 95% CI 1.22–1.36; Hispanic–U, AOR = 1.25, 95% CI 1.23–1.27; and Hispanic–R, AOR = 1.17, 95% CI 1.08–1.27), and increased risks for breast cancer death (NH-black–U, AHR = 1.46, 95% CI 1.43–1.50; NH-black–R, AHR = 1.42, 95% CI 1.32–1.53; and Hispanic–U, AHR = 1.10, 95% CI 1.07–1.13). Conclusion Regardless of rurality, NH-black and Hispanic women had significantly increased odds of late-stage diagnosis, no receipt of treatment, and risk of breast cancer death.

Funder

National Institute on Minority Health and Health Disparities

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3